ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,281.55
0.53%
Dow Jones
39,411.21
0.67%
Gold vs US Dollar
2,328.86
-0.09%
Brent Oil
85.235
-0.04%
Bitcoin
60,963.70
1.16%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
25/06/202406:46Alliance NewsAlliance NewsLONDON MARKET EARLY CALL: FTSE 100 to rise despite US tech slump
25/06/202406:30Alliance NewsAlliance NewsGET READY: Augmentum Fintech, IG Design, Warehouse REIT at 0700 BST
25/06/202406:30Alliance NewsAlliance NewsAlliance News UK - start of day
25/06/202406:30UK RegulatoryA new wording of Articles of Association of Invalda INVL has been registered. The issued shares were acquired by the group's employeesLSE:0IJBInvalda Invl Ab
25/06/202406:30UK RegulatoryInformation about shares issued by Invalda INVL and votes grantedLSE:0IJBInvalda Invl Ab
25/06/202406:28PR Newswire (US)MONOPOLY DREAMS™ HONG KONG OFFERS HOT DEALS FOR THIS HILARIOUS SUMMER
25/06/202406:15PR Newswire (US)Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple SclerosisNASDAQ:HALOHalozyme Therapeutics Incorporated
25/06/202406:01PR Newswire (US)MONOPOLY DREAMS™ HONG KONG OFFERS HOT DEALS FOR THIS HILARIOUS SUMMER
25/06/202406:00UK RegulatoryRoche’s OCREVUS subcutaneous administration approved by European Commission, as first and only twice-a-year injection for relapsing and primary progressive multiple sclerosisLSE:0QQ6Roche Holding Ag
25/06/202406:00PR Newswire (US)WRJ Design Announces Opening of "Stags Landing" New Headquarters, Designer Showroom, Private Residence, Art Gallery and Event Space in Jackson Hole
25/06/202406:00PR Newswire (US)CellPoint Digital Partners with Nexus Tours, Leader in Destination Management, To Enhance Its Payment Infrastructure
25/06/202406:00UK RegulatoryPR Newswire - Start of Day
25/06/202406:00PR Newswire (US)CellPoint Digital Partners with Nexus Tours, Leader in Destination Management, To Enhance Its Payment Infrastructure
25/06/202405:53Alliance NewsAlliance NewsIsrael bombs Gaza as US warns against wider war, escalation
25/06/202405:50Alliance NewsAlliance NewsChina Premier Li Qiang calls to "oppose decoupling" at economic forum
25/06/202405:43PR Newswire (US)Global Times: 'History, Sovereignty of S.China Sea Islands' debuts at 2024 BIBF, bridging gap between research and international law studies
25/06/202405:38Alliance NewsAlliance NewsGermany's Baerbock, in Israel, calls for ways to end Gaza violence
25/06/202405:36Alliance NewsAlliance NewsCorporations urge Japan to triple renewables capacity by 2035
25/06/202405:35Alliance NewsAlliance NewsTOP NEWS: EU sanctions Chinese firms over links to Russian war effort
25/06/202405:30PR Newswire (US)Explore Madrid Like Never Before: New Partnership Between Wego and MADRID TURISMO by IFEMA Madrid
25/06/202405:30PR Newswire (US)Explore Madrid Like Never Before: New Partnership Between Wego and MADRID TURISMO by IFEMA Madrid
25/06/202405:22Alliance NewsAlliance NewsGLOBAL BRIEFING: European stocks called mixed after Nasdaq ends in red
25/06/202405:01PR Newswire (US)Corporates' Supply Chain Scope 3 Emissions Are 26 Times Higher Than Their Operational Emissions
25/06/202405:01PR Newswire (US)CISOs Growing More Comfortable With Risk, But Better C-Suite Alignment Needed: Netskope Research
25/06/202405:01PR Newswire (US)U.S. News Releases 2024-2025 Best Global Universities Rankings
25/06/202405:01PR Newswire (US)INRIX: Remote and Hybrid Work Shift Can't Curb Congestion
25/06/202405:01PR Newswire (US)TRIPADVISOR UNVEILS TRAVELERS' CHOICE AWARDS BEST OF THE BEST THINGS TO DONASDAQ:TRIPTripAdvisor Inc
25/06/202405:00PR Newswire (US)New political satire book enlightens and amuses, urging readers to oppose a corrupt, authoritarian federal government
25/06/202405:00PR Newswire (US)NEW BOOK INCORPORATES CUTTING-EDGE RESEARCH TO CUSTOMIZE LEADERSHIP STYLES BASED ON NINE DISTINCTIVE PATTERNS
25/06/202405:00PR Newswire (US)Dino Rizzo Celebrates Upcoming Serve Day and Convoy of Hope Collaboration

Your Recent History

AMEX
EAM
EXMO
FLOKIUSDT
FLOKI
BOV
GRND3F
GRENDENE ON
USOTC
YAMHF
Yamaha Motor (PK)
BIT
UB3RW5
Unicredit Bank
LSE
QV06
Mor.st.fin 25
USOTC
BTRMF
Battery Mineral Resources (QB)
USOTC
VADP
Vado (PK)
NASDAQ
AAYCMXX
Hsbc Usa Inc Capped Dual...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved